Copyright
©The Author(s) 2019.
World J Clin Cases. Nov 6, 2019; 7(21): 3553-3561
Published online Nov 6, 2019. doi: 10.12998/wjcc.v7.i21.3553
Published online Nov 6, 2019. doi: 10.12998/wjcc.v7.i21.3553
Figure 1 Serial computed tomography of liver tumors in a patient with methotrexate-associated lymphoproliferative disorder.
Before (A) and after discontinuation of methotrexate at (B) 2 wk; (C) 1 mo; and (D) 2 mo, at which point all liver tumors had disappeared.
- Citation: Mizusawa T, Kamimura K, Sato H, Suda T, Fukunari H, Hasegawa G, Shibata O, Morita S, Sakamaki A, Yokoyama J, Saito Y, Hori Y, Maruyama Y, Yoshimine F, Hoshi T, Morita S, Kanefuji T, Kobayashi M, Terai S. Methotrexate-related lymphoproliferative disorders in the liver: Case presentation and mini-review. World J Clin Cases 2019; 7(21): 3553-3561
- URL: https://www.wjgnet.com/2307-8960/full/v7/i21/3553.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v7.i21.3553